Control of Cardiac Output with Ivabradine or Beta-Blockers for Refractory Hypoxemia under Veno-Venous ECMO for Severe ARDS
Ivabradine and beta-blockers were clinically well-tolerated and improved the ECMO flow/CO ratio in patients with refractory hypoxemia during VV-ECMO. However, the improvement of arterial oxygenation was associated with decreased DO<sub>2</sub>.
Authors
- Armand Mekontso Dessap (ORCID: https://orcid.org/0000-0001-5961-5577)
- Paul Masi (ORCID: https://orcid.org/0000-0002-5817-2257)
- Lionel Tchatat Wangueu
- Thierry A Folliguet (ORCID: https://orcid.org/0000-0003-0009-6543)
- François Bagate (ORCID: https://orcid.org/0000-0002-3391-0807)
- Alexandra Plesa (ORCID: https://orcid.org/0000-0002-1822-9589)
Institutions
- Université Paris-Est Créteil (FR)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
Publication Details
- Journal
- Cardiovascular Drugs and Therapy
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1007/s10557-024-07650-5
- Citations
- 3
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.55